Merit Medical Systems Inc. Reports Q2 2026 Results

What Happened
On July 30, 2026, Merit Medical Systems, Inc. announced its operating and financial results for the quarter ended June 30, 2026 via a press release and held a conference call/webcast to discuss the results. The press release (furnished as Exhibit 99.1) is titled “Merit Medical Reports Second Quarter 2026 Results and Updates Full‑Year 2026 Guidance” and includes unaudited financial information. A conference call and live webcast, with a presentation (furnished as Exhibit 99.2), were made available on merit.com. The Form 8‑K reporting these items was signed by Brian G. Lloyd, Chief Legal Officer and Corporate Secretary.

Key Details

• Filing date: July 30, 2026 (Form 8‑K Items 2.02 and 7.01).
• Press release with Q2 2026 results and an update to full‑year 2026 guidance is Exhibit 99.1.
• Conference call/webcast and presentation are available and furnished as Exhibit 99.2; webcast accessible at merit.com.
• The press release states the financial information is unaudited (see Exhibit 99.1).

Why It Matters
This 8‑K signals that Merit disclosed its latest quarterly earnings and updated its full‑year guidance—information that can affect investor expectations for revenue, earnings, and stock performance. Investors should review the press release and the conference call presentation (Exhibits 99.1 and 99.2) for specific metrics—revenue, net income, EPS, cash flow, and any guidance revisions—since the Form 8‑K itself references those documents rather than listing detailed figures.